Paul Sauer Vaxcyte, Inc. (PCVX) insider trading activity

Paul Sauer is SVP Process Dev, Manufacturing of Vaxcyte, Inc.. Currently has a direct ownership of 13,822 shares of PCVX, which is worth approximately $1.2 Million. The most recent transaction as insider was on Sep 02, 2022, when has been sold 865 shares (Common Stock) at a price of $26.38 per share, resulting in proceeds of $22,819. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.8K

0% 3M change

0% 12M change

Total Value Held $1.2 Million

Paul Sauer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2022	SELL Payment of exercise price or tax liability	$22,819 $26.38 p/Share	865 Reduced 5.89%	13,822 Common Stock
Aug 22 2022	SELL Open market or private sale	$77,790 $25.93 p/Share	3,000 Reduced 16.96%	14,687 Common Stock
Jul 27 2022	SELL Open market or private sale	$75,000 $25.0 p/Share	3,000 Reduced 14.5%	17,687 Common Stock
Jul 20 2022	SELL Open market or private sale	$75,000 $25.0 p/Share	3,000 Reduced 12.67%	20,687 Common Stock
May 23 2022	SELL Open market or private sale	$78,660 $26.22 p/Share	3,000 Reduced 11.24%	23,687 Common Stock
Apr 22 2022	SELL Open market or private sale	$75,000 $25.0 p/Share	3,000 Reduced 10.67%	25,125 Common Stock
Mar 22 2022	SELL Open market or private sale	$75,000 $25.0 p/Share	3,000 Reduced 9.64%	28,125 Common Stock
Mar 10 2022	SELL Open market or private sale	$150,000 $25.0 p/Share	6,000 Reduced 16.16%	31,125 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	10,000 Added 21.22%	37,125 Common Stock
Dec 29 2021	SELL Open market or private sale	$150,000 $25.0 p/Share	6,000 Reduced 18.11%	27,125 Common Stock
Nov 01 2021	SELL Open market or private sale	$75,000 $25.0 p/Share	3,000 Reduced 8.3%	33,125 Common Stock
Sep 22 2021	SELL Open market or private sale	$133,736 $25.2 p/Share	5,307 Reduced 12.81%	36,125 Common Stock
Apr 05 2021	SELL Other acquisition or disposition	-	38,308 Reduced 49.18%	39,591 Common Stock
Mar 11 2021	SELL Open market or private sale	$62,500 $25.0 p/Share	2,500 Reduced 3.11%	77,899 Common Stock
Mar 11 2021	BUY Exercise of conversion of derivative security	$4,475 $1.79 p/Share	2,500 Added 3.02%	80,399 Common Stock
Feb 11 2021	SELL Open market or private sale	$67,300 $26.92 p/Share	2,500 Reduced 3.11%	77,899 Common Stock
Feb 11 2021	BUY Exercise of conversion of derivative security	$4,475 $1.79 p/Share	2,500 Added 3.02%	80,399 Common Stock
Jan 11 2021	SELL Open market or private sale	$65,150 $26.06 p/Share	2,500 Reduced 3.11%	77,899 Common Stock
Jan 11 2021	BUY Exercise of conversion of derivative security	$4,475 $1.79 p/Share	2,500 Added 3.02%	80,399 Common Stock

Paul Sauer

SVP Process Dev, Manufacturing

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account